Tae-Min Cho

A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response

J. Seo, Jihyae Ann, Jeewoo Lee, 2022, Oncogene.

Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1

Joohyun Woo, H. Kwon, W. Lim, 2021, PloS one.

C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.

Ji Young Kim, J. Seo, Jihyae Ann, 2019, Cancer letters.

Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.

Ji Young Kim, J. Seo, Y. Kim, 2017, Cancer letters.

AKT signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells.

Wun-Jae Kim, S. Moon, Tae-Min Cho, 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.

Ji Young Kim, J. Seo, Y. Kim, 2017, Cellular signalling.

Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.

Ji Young Kim, J. Seo, Eunhye Oh, 2016, Cancer letters.

Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells.

Ji Young Kim, J. Seo, Y. Kim, 2017, Biochemical and biophysical research communications.

Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.

Ji Young Kim, J. Seo, Lee Farrand, 2018, Cancer letters.

MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.

Wun-Jae Kim, S. Moon, Jun-Hui Song, 2015, Oncology reports.

Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents.

Ji Young Kim, Hyun-Ju Park, Kyu-Won Kim, 2019, Bioorganic & medicinal chemistry.

Flubendazole elicits anti‐metastatic effects in triple‐negative breast cancer via STAT3 inhibition

Ji Young Kim, J. Seo, Lee Farrand, 2018, International Journal of Cancer.